These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6210093)

  • 1. Neonatal chlordecone alteration of the ontogeny of sex-differentiated hepatic drug and xenobiotic metabolizing enzymes.
    Lamartiniere CA; Nicholas JM
    Biochem Pharmacol; 1984 Dec; 33(24):4092-5. PubMed ID: 6210093
    [No Abstract]   [Full Text] [Related]  

  • 2. Fractional hepatic localization of 14CHCl3 in mice and rats treated with chlordecone or mirex.
    Hewitt LA; Hewitt WR; Plaa GL
    Fundam Appl Toxicol; 1983; 3(6):489-95. PubMed ID: 6198233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microsomal p-nitroanisole O-demethylase. Effects of chlordecone or mirex induction in male and female rats.
    Ebel RE
    Biochem Pharmacol; 1984 Feb; 33(4):559-64. PubMed ID: 6200121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spermotoxicity and tissue accumulation of chlordecone (Kepone) in male rats.
    Linder RE; Scotti TM; McElroy WK; Laskey JW; Strader LF; Powell K
    J Toxicol Environ Health; 1983; 12(2-3):183-92. PubMed ID: 6197529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of chlordecone in a two-stage model of hepatocarcinogenesis: a significant sex difference in the hepatocellular carcinoma incidence.
    Sirica AE; Wilkerson CS; Wu LL; Fitzgerald R; Blanke RV; Guzelian PS
    Carcinogenesis; 1989 Jun; 10(6):1047-54. PubMed ID: 2470527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole coinduces multiple xenobiotic-metabolizing enzymes in the rat.
    Kashfi K; Dannenberg AJ
    Ann N Y Acad Sci; 1995 Sep; 768():237-42. PubMed ID: 8526355
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of strain and diet upon constitutive and chemically induced activities of several xenobiotic-metabolizing enzymes in rats.
    Stott WT; Kan HL; McFadden LG; Sparrow BR; Gollapudi BB
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):325-33. PubMed ID: 15135211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of long-term consequences in behavioral and/or neural function following neonatal chlordecone exposure.
    Mactutus CF; Tilson HA
    Teratology; 1985 Apr; 31(2):177-86. PubMed ID: 2581329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A semiquantitative morphologic assessment of chlordecone-potentiated chloroform hepatotoxicity.
    Iijima M; Côté MG; Plaa GL
    Toxicol Lett; 1983 Jul; 17(3-4):307-14. PubMed ID: 6194577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase.
    Fujisaki H; Mise M; Ishii Y; Yamada H; Oguri K
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1024-31. PubMed ID: 7906730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of brominated halomethane hepatotoxicity by chlordecone in the male rat.
    Klingensmith JS; Mehendale HM
    Toxicol Appl Pharmacol; 1981 Dec; 61(3):378-84. PubMed ID: 6173934
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of vitamin A deficiency on hepatic and intestinal drug metabolizing enzymes in rats.
    Gupta PH; Mehta S; Mehta SK
    Biochem Int; 1989 Jul; 19(1):123-33. PubMed ID: 2505773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlordecone-induced hepatic dysfunction.
    Mehendale HM
    J Toxicol Environ Health; 1981; 8(5-6):743-55. PubMed ID: 6175767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplicity of liver drug metabolizing enzymes.
    Lu AY
    Drug Metab Rev; 1979; 10(2):187-208. PubMed ID: 121803
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of hepatic bilirubin-metabolizing enzymes by the traditional Chinese medicine yin zhi huang.
    Yin J; Miller M; Wennberg RP
    Dev Pharmacol Ther; 1991; 16(3):176-84. PubMed ID: 1914791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of fat deficiency on hepatic and pulmonary drug metabolizing enzymes in rat and mouse.
    Koul IB; Koul A; Gandhi RK; Sharma RR; Khanduja KL
    Biochem Int; 1990; 20(5):979-89. PubMed ID: 2112386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pleiotropic response to phenobarbital-type enzyme inducers in the F344/NCr rat. Effects of chemicals of varied structure.
    Lubet RA; Dragnev KH; Chauhan DP; Nims RW; Diwan BA; Ward JM; Jones CR; Rice JM; Miller MS
    Biochem Pharmacol; 1992 Mar; 43(5):1067-78. PubMed ID: 1372805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resiliency to amplification of carbon tetrachloride hepatotoxicity by chlordecone during postnatal development in rats.
    Cai Z; Mehendale HM
    Pediatr Res; 1993 Mar; 33(3):225-32. PubMed ID: 7681558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term chlordecone toxicity in rats including effects on reproduction, pathological organ changes, and their reversibility.
    Cannon SB; Kimbrough RD
    Toxicol Appl Pharmacol; 1979 Mar; 47(3):469-76. PubMed ID: 87035
    [No Abstract]   [Full Text] [Related]  

  • 20. Dynamics of the localization of drug metabolizing enzymes in tissues and cells.
    Wolf CR; Buchmann A; Friedberg T; Moll E; Kuhlmann WD; Kunz HW; Oesch F
    Biochem Soc Trans; 1984 Feb; 12(1):60-2. PubMed ID: 6705990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.